Global Medical REIT Inc.
GMRE · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.16 | -0.02 | 0.05 | -0.13 |
| FCF Yield | -24.63% | 40.13% | -64.18% | -61.64% |
| EV / EBITDA | 8.18 | 6.88 | 8.02 | 9.23 |
| Quality | ||||
| ROIC | 2.69% | 3.07% | 2.85% | 2.99% |
| Gross Margin | 78.87% | 80.07% | 81.64% | 86.63% |
| Cash Conversion Ratio | 10.56 | 3.32 | 3.83 | 3.76 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.30% | 6.77% | 13.62% | 17.86% |
| Free Cash Flow Growth | -142.94% | 173.30% | 39.97% | 27.99% |
| Safety | ||||
| Net Debt / EBITDA | 7.07 | 5.58 | 6.81 | 6.71 |
| Interest Coverage | 1.14 | 1.23 | 1.53 | 1.88 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -185.20 | -148.11 | -178.32 | -224.13 |